Bloom MD vs Trimi Health
An in-depth comparison of two leading GLP-1 Providers
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
Trimi Health
Best for: knowing which pharmacy fills the vial — it names VialsRx
Visit Trimi Health →Two GLP-1 Providers chasing the same patients, trading off price, geography and what lands in the box differently. On our scoring, Trimi Health opens cheaper — $99/mo against $245, and Trimi Health finishes ahead, 9.4 to 7.1. What follows: the prices, what each plan actually covers, the six-dimension score, where each one is weak, and who should pick which.
Pricing
Bloom MD
Flat 'Any Dose' monthly. Also 90-day $750; 10-week new-patient starter $395.
Scales by dose: 4.4mg $395, 7mg $445, 10mg $495, 13mg $595. 90-day plans $775–$1,385.
From $395/mo, scales to $595.
Microdose GLP-1 (tirzepatide).
Oral GLP-1 drops.
Membership only — the $75/mo does NOT include the cost of the medication.
Trimi Health
Billed monthly. Flat price at every dose.
Quarterly plan: billed $435 every 3 months.
Bi-annual plan: billed $720 every 6 months.
Annual plan: billed $1,188 yearly upfront (or BNPL via Affirm/Klarna/Afterpay). This is the advertised headline price.
Billed monthly. Flat price at every dose.
Quarterly plan: billed $597 every 3 months.
6-month plan: billed $1,050 every 6 months.
Annual plan: billed $1,500 yearly upfront (or BNPL). This is the advertised headline price.
What’s included
Bloom MD
Inclusions not disclosed.
Trimi Health
Covered by the monthly price
Medication
In the price
Clinician visits
In the price
Shipping
In the price
Lab work
Not stated
Coaching
Not stated
Score breakdown
Both providers are scored on the same six-dimension framework. The gradient bar marks the stronger side on each dimension.
Bloom MD
7.1/10
Trimi Health
9.4/10
Value25%
Effectiveness25%
User Experience15%
Trust & Safety15%
Accessibility10%
Support10%
Features & Coverage
| Feature | Bloom MD | Trimi Health |
|---|---|---|
| Starting Price | $245/mo | ✓$99/mo |
| Features | 0 features | ✓3 features |
| States Available | Not disclosed | 50 |
| Compounded | ✓ Yes | ✓ Yes |
| Brand Name | — | — |
| FSA/HSA Accepted | — | — |
| FDA Warnings | None | None |
About Bloom MD
Weight loss, longevity, and wellness are the lines Bloom MD (bloommd.com) advertises. A user confirmed the GLP-1 offering. We could not pull the product details ourselves, because the storefront runs on Shopify and renders its pages in JavaScript.
Read our full Bloom MD review →About Trimi Health
Trimi Health is a telehealth seller whose compounded GLP-1 pricing is among the lowest available.
Read our full Trimi Health review →Pros & Cons
Bloom MD
What we like
- Publishes a price on its own site before the medical questionnaire, so it can be compared without handing over health information
- No FDA warning letter matched this operator when we searched our enforcement register
Watch-outs
- Semaglutide at $295 a month, 56% above the $189 register median for the same drug and form
- No state list is on record here, so whether it serves your state cannot be confirmed from this page
- No dispensing pharmacy is named in our record, so its accreditation cannot be looked up from here
- Its liraglutide and semaglutide and tirzepatide are compounded rather than FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality
Trimi Health
What we like
- Semaglutide at $99 a month, 48% below the $189 median for the same drug and form across this register
- Tirzepatide at $125 a month, 53% below the $267 median for the same drug and form across this register
- Publishes a price on its own site before the medical questionnaire, so it can be compared without handing over health information
- The monthly price is recorded as flat across doses, so it does not climb as the dose is titrated up
- The monthly figure covers medication, consult, shipping
- Coverage is published for all 50 states
- Names 2 dispensing pharmacies, which most sellers in this register do not do
- No FDA warning letter matched this operator when we searched our enforcement register
Watch-outs
- Its semaglutide and tirzepatide are compounded rather than FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality
Our Verdict
Trimi Health takes it, 9.4 against 7.1, and it is especially strong on knowing which pharmacy fills the vial — it names VialsRx. Bloom MD is no weak second and may fit you better on starting below a standard dose, with microdose tiers.
Choose Bloom MD if…
You want starting below a standard dose, with microdose tiers and an opening price near $245 a month.
Choose Trimi Health if…
You want knowing which pharmacy fills the vial — it names VialsRx and an opening price near $99 a month.
Ready to start? Vetted GLP-1 providers
Vetted telehealth providers that prescribe GLP-1 online.
No insurance needed · vetted by our editors
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
Strut Health
Semaglutide at $99/month, 48% under the register median
From $99/mo
Get started →Oak
Semaglutide at $119/month, 37% under the register median
From $119/mo
Get started →Direct Meds
Compounded semaglutide at $249/month
From $249/mo
Get started →Bloom MD vs Trimi Health: FAQ
Glossary
The words sellers use, defined. Tap any term.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Related comparisons
Continue exploring Bloom MD and Trimi Health head-to-heads in the same category.
- Bloom MD vs Embody
- Bloom MD vs He & She MD
- Bloom MD vs Lean Meds
- Trimi Health vs NextMeds
- Trimi Health vs bmiMD
- Trimi Health vs CoreAge Rx
Or see the full category ranking.
Novo Nordisk A/S owns the Wegovy®, Ozempic® and Rybelsus® marks; Eli Lilly and Company owns Mounjaro® and Zepbound®. Every other product name and mark on this page belongs to whoever owns it. No pharmaceutical manufacturer is affiliated with GLP Watchdog. See trademark disclaimer.